Genotypic recombination and hepatitis C virus;Recombinaison génétique et virus de l'hépatite C

Virologie

Volumn 12, Issue 1, 2008, Pages 7-14

  Legrand Abravanel, F ^a,b   Izopet, J ^a,b  

^a France   (France)

^b CHU PURPAN   (France)

Author keywords

Hepatitis C virus; Intragenotypic or intergenotypic recombination; Replicative or non replicative recombination

Indexed keywords

FLAVIVIRUS; GENETIC RECOMBINATION; GENOTYPE; HEPATITIS C VIRUS; NONHUMAN; NUCLEOTIDE SEQUENCE; PHYLOGENY; REVIEW; VIRAL GENETICS; VIRUS CHARACTERIZATION; VIRUS RECOMBINANT; VIRUS RECOMBINATION; VIRUS STRAIN; VIRUS TYPING;

FLAVIVIRIDAE; HEPACIVIRUS; HEPATITIS C VIRUS;

EID: 41749101048     PISSN: 12678694     EISSN: None     Source Type: Journal    
DOI: 10.1684/vir.2008.0139     Document Type: Review

References (61)

1. Choo QL, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 1989 ; 244 : 359-62.
2. Simmonds P, Bukh J, Combet C, et al. Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes. Hepatology 2005 ; 42 : 962-73.
3. Lindenbach BD, Evans MJ, Syder AJ, et al. Complete replication of hepatitis C virus in cell culture. Science 2005 ; 309 : 623-6.
4. Wakita T, Pietschmann T, Kato T, et al. Production of infectious hepatitis C virus in tissue culture from a cloned viral genome. Nat Med 2005 ; 11 : 791-6.
5. Zhong J, Gastaminza P, Cheng G, et al. Robust hepatitis C virus infection in vitro. Proc Natl Acad Sci USA 2005 ; 102 : 9294-9.
6. Pietschmann T, Kaul A, Koutsoudakis G, et al. Construction and characterization of infectious intragenotypic and intergenotypic hepatitis C virus chimeras. Proc Natl Acad Sci USA 2006 ; 103 : 7408-13.
7. Yi M, Ma Y, Yates J, Lemon SM. Compensatory mutations in E1, p7, NS2, and NS3 enhance yields of cell culture-infectious intergenotypic chimeric hepatitis C virus. J Virol 2007 ; 81 : 629-38.
8. Manns MP, McHutchison JG, Gordon SC, et al. Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C : a randomised trial. Lancet 2001 ; 358 : 958-65.
9. Fried MW, Shiffman ML, Reddy KR, et al. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. N Engl J Med 2002 ; 347 : 975-82.
10. Legrand-Abravanel F, Nicot F, Boulestin A, et al. Pegylated interferon and ribavirin therapy for chronic hepatitis C virus genotype 4 infection. J Med Virol 2005 ; 77 : 66-9.
11. Hui CK, Yuen MF, Sablon E, Chan AO, Wong BC, Lai CL. Interferon and ribavirin therapy for chronic hepatitis C virus genotype 6 : a comparison with genotype 1. J Infect Dis 2003 ; 187 ; 1071-4.
12. Legrand-Abravanel F, Sandres-Saune K, Barange K, et al. Hepatitis C virus genotype 5 : epidemiological characteristics and sensitivity to combination therapy with interferon-alpha plus ribavirin. J Infect Dis 2004 ; 189 : 1397-400.
13. Becher P, Orlich M, Konig M, Thiel HJ. Nonhomologous RNA recombination in bovine viral diarrhea virus : molecular characterization of a variety of subgenomic RNAs isolated during an outbreak of fatal mucosal disease. J Virol 1999 ; 73 : 5646-53.
14. Gallei A, Pankraz A, Thiel HJ, Becher P. RNA recombination in vivo in the absence of viral replication. J Virol 2004 ; 78 : 6271-81.
15. Gallei A, Rumenapf T, Thiel HJ, Becher P. Characterization of helper virus-independent cytopathogenic classical swine fever virus generated by an in vivo RNA recombination system. J Virol 2005 ; 79 : 2440-8.
16. Kosmidou A, Buttner M, Meyers G. Isolation and characterization of cytopathogenic classical swine fever virus (CSFV). Arch Virol 1998 ; 143 : 1295-309.
17. Holmes EC, Worobey M, Rambaut A. Phylogenetic evidence for recombination in dengue virus. Mol Biol Evol 1999 ; 16 : 405-9.
18. Tolou HJ, Couissinier-Paris P, Durand JP, et al. Evidence for recombination in natural populations of dengue virus type 1 based on the analysis of complete genome sequences. J Gen Virol 2001 ; 82 : 1283-90.
19. Twiddy SS, Holmes EC. The extent of homologous recombination in members of the genus Flavivirus. J Gen Virol 2003 ; 84 : 429-40.
20. Worobey M, Rambaut A, Holmes EC. Widespread intra-serotype recombination in natural populations of dengue virus. Proc Natl Acad Sci USA 1999 ; 96 : 7352-7.
21. Worobey M, Holmes EC. Homologous recombination in GB virus C/hepatitis G virus. Mol Biol Evol 2001 ; 18 : 254-61.
22. Kalinina O, Norder H, Mukomolov S, Magnius LO. A natural intergenotypic recombinant of hepatitis C virus identified in St. Petersburg. J Virol 2002 ; 76 : 4034-43.
23. Ledinko N. Genetic recombination with poliovirus type 1. Studies of crosses between a normal horse serum-resistant mutant and several guanidine-resistant mutants of the same strain. Virology 1963 ; 20 : 107-19.
24. Simon-Lorière E, Galetto R, Negroni M. Caractéristique mécanistique de la recombinaison chez le virus de l'immunodé ficience humaine. Virologie 2006 ; 10 : 431-42.
25. Posada D, Crandall KA, Holmes EC. Recombination in evolutionary genomics. Annu Rev Genet 2002 ; 36 : 75-97.
26. Worobey M, Holmes EC. Evolutionary aspects of recombination in RNA viruses. J Gen Virol 1999 ; 80 : 2535-43.
27. Nora T, Charpentier C, Tenaillon O, Hoede C, Clavel F, Hance AJ. Contribution of recombination to the evolution of human immunodeficiency viruses expressing resistance to antiretroviral treatment. J Virol 2007 ; 81 : 7620-8.
28. Legrand-Abravanel F, Claudinon J, Nicot F, et al. New natural intergenotypic (2/5) recombinant of hepatitis C virus. J Virol 2007 ; 81 : 4357-62.
29. Meyers G, Stoll D, Gunn M. Insertion of a sequence encoding light chain 3 of microtubule-associated proteins 1A and 1B in a pestivirus genome : connection with virus cytopathogenicity and induction of lethal disease in cattle. J Virol 1998 ; 72 : 4139-48.
30. Desport M, Collins ME, Brownlie J. Genome instability in BVDV : an examination of the sequence and structural influences on RNA recombination. Virology 1998 ; 246 : 352-61.
31. AbuBakar S, Wong PF, Chan YF. Emergence of dengue virus type 4 genotype HA in Malaysia. J Gen Virol 2002 ; 83 : 2437-42.
32. Uzcategui NY, Camacho D, Comach G, Cuello de Uzcategui R, Holmes EC, Gould EA. Molecular epidemiology of dengue type 2 virus in Venezuela : evidence for in situ virus evolution and recombination. J Gen Virol 2001 ; 82 : 2945-53.
33. Holmes EC, Twiddy SS. The origin, emergence and evolutionary genetics of dengue virus. Infect Genet Evol 2003 ; 3 : 19-28.
34. Noppornpanth S, Lien TX, Poovorawan Y, Smits SL, Osterhaus AD, Haagmans BL. Identification of a naturally occurring recombinant genotype 2/6 hepatitis C virus. J Virol 2006 ; 80 : 7569-77.
35. Kageyama S, Agdamag DM, Alesna ET, et al. A natural intergenotypic (2b/1b) recombinant of hepatitis C virus in the Philippines. J Med Virol 2006 ; 78 : 1423-8.
36. Cristina J, Colina R. Evidence of structural genomic region recombination in Hepatitis C virus. Virol J 2006 ; 3 : 53.
37. Colina R, Casane D, Vasquez S, et al. Evidence of intratypic recombination in natural populations of hepatitis C virus. J Gen Virol 2004 ; 85 : 31-7.
38. Gao F, Nainan OV, Khudyakov Y, et al. Recombinant hepatitis C virus in experimentally infected chimpanzees. J Gen Virol 2007 ; 88 : 143-7.
39. Fan X, Lang DM, Xu Y, et al. Liver transplantation with hepatitis C virus-infected graft : interaction between donor and recipient viral strains. Hepatology 2003 ; 38 : 25-33.
40. Bernardin F, Herring B, Page-Shafer K, Kuiken C, Delwart E. Absence of HCV viral recombination following superinfection. J Viral Hepat 2006 ; 13 : 532-7.
41. Gottwein JM, Scheel TK, Hoegh AM, et al. Robust hepatitis C genotype 3a cell culture releasing adapted intergenotypic 3a/2a (S52/JFH1) viruses. Gastroenterology 2007 ; 133 : 1614-26.
42. Astier-Gin T, Bellecave P, Litvak S, Ventura M. Template requirements and binding of hepatitis C virus NS5B polymerase during in vitro RNA synthesis from the 3′-end of virus minus-strand RNA. FEBS J 2005 ; 272 : 3872-86.
43. Appel N, Herian U, Bartenschlager R. Efficient rescue of hepatitis C virus RNA replication by trans-complementation with non-structural protein 5A. J Virol 2005 ; 79 : 896-909.
44. Yagi S, Mori K, Tanaka E, et al. Identification of novel HCV subgenome replicating persistently in chronic active hepatitis C patients. J Med Virol 2005 ; 77 : 399-413.
45. Bernardin F, Stramer SL, Rehermann B, et al. High levels of subgenomic HCV plasma RNA in immunosilent infections. Virology 2007 ; 365 : 446-56.
46. Noppornpanth S, Smits SL, Lien TX, Poovorawan Y, Osterhaus AD, Haagmans BL. Characterization of hepatitis C virus deletion mutants circulating in chronically infected patients. J Virol 2007 ; 81 : 12496-503.
47. Payan C, Roudot-Thoraval F, Marcellin P, et al. Changing of hepatitis C virus genotype patterns in France at the beginning of the third millenium : The GEMHEP GenoCII Study. J Viral Hepat 2005 ; 12 : 405-13.
48. Sandres-Saune K, Deny P, Pasquier C, Thibaut V, Duverlie G, Izopet J. Determining hepatitis C genotype by analyzing the sequence of the NS5b region. J Virol Methods 2003 ; 109 : 187-93.
49. Schaller T, Appel N, Koutsoudakis G, et al. Analysis of hepatitis C virus superinfection exclusion by using novel fluorochrome gene-tagged viral genomes. J Virol 2007 ; 81 : 4591-603.
50. Tscherne DM, Evans MJ, von Hahn T, et al. Superinfection exclusion in cells infected with hepatitis C virus. J Virol 2007 ; 81 : 3693-703.
51. Neumann AU, Lam NP, Dahari H, et al. Hepatitis C viral dynamics in vivo and the antiviral efficacy of interferon-alpha therapy. Science 1998 ; 282 : 103-7.
52. Figlerowicz M, Alejska M, Kurzynska-Kokorniak A, Figlerowicz M. Genetic variability : the key problem in the prevention and therapy of RNA-based virus infections. Med Res Rev 2003 ; 23 : 488-518.
53. Kalinina O, Norder H, Magnius LO. Full-length open reading frame of a recombinant hepatitis C virus strain from St Petersburg : propose mechanism for its formation. J Gen Virol 2004 ; 85 : 1853-7.
54. Moreau I, Hegarty S, Levis J, et al. Serendipitous identification of natural intergenotypic recombinants of hepatitis C in Ireland. Virol J 2006 ; 3 : 95.
55. Tallo T, Norder H, Tefanova V, et al. Genetic characterization of hepatitis C virus strains in Estonia : fluctuations in the predominating subtype with time. J Med Virol 2007 ; 79 : 374-82.
56. Thomas F, Nicot F, Sandres-Saune K, et al. Genetic diversity of HCV genotype 2 strains in south western France. J Med Virol 2007 ; 79 : 26-34.
57. Lancaster MU, Hodgetts SI, Mackenzie JS, Urosevic N. Characterization of defective viral RNA produced during persistent infection of Vero cells with Murray Valley encephalitis virus. J Virol 1998 ; 72 : 2474-82.
58. Yoon SW, Lee SY, Won SY, Park SH, Park SY, Jeong YS. Characterization of homologous defective interfering RNA during persistent infection of Vero cells with Japanese encephalitis virus. Mol Cells 2006 ; 21 : 112-20.
59. Huang AS, Baltimore D. Defective viral particles and viral disease processes. Nature 1970 ; 226 : 325-7.
60. Reiser M, Hinrichsen H, Benhamou Y, et al. Antiviral efficacy of NS3-serine protease inhibitor BILN-2061 in patients with chronic genotype 2 and 3 hepatitis C. Hepatology 2005 ; 41 : 832-5.
61. Graham DJ, Stahlhut M, Flores O, et al. A genotype 2b NS5B polymerase with novel substitutions supports replication of a chimeric HCV 1b : 2b replicon containing a genotype 1b NS3-5A background. Antiviral Res 2006 ; 69 : 24-30.